Wells Fargo’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1
Closed -$30 7162
2024
Q2
$30 Hold
1
﹤0.01% 6430
2024
Q1
$32 Hold
1
﹤0.01% 6970
2023
Q4
$30 Hold
1
﹤0.01% 7075
2023
Q3
$27 Hold
1
﹤0.01% 7111
2023
Q2
$32 Buy
+1
New +$36 ﹤0.01% 7184
2023
Q1
Hold
0
7548
2022
Q1
Sell
-1
Closed -$40 8041
2021
Q4
$0 Hold
1
﹤0.01% 7992
2021
Q3
$0 Hold
1
﹤0.01% 7683
2021
Q2
$0 Hold
1
﹤0.01% 7618
2021
Q1
$0 Hold
1
﹤0.01% 7542
2020
Q4
$0 Buy
+1
New +$54 ﹤0.01% 7172
2020
Q2
Sell
-29
Closed -$1K 6970
2020
Q1
$1K Buy
+29
New +$1.06K ﹤0.01% 6099

Wells Fargo's BTEC Position: Q3 2024 in Review

Wells Fargo sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q3 2024, closing a stake of 1 share — an estimated $30 sold.

Wells Fargo first reported a position in BTEC in Q1 2020 and held it in 11 quarters. The position peaked at $1K in Q1 2020. 0 funds tracked by Wall St. Rank hold BTEC as of Q3 2024.

  • Wells Fargo reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q3 2024 after selling out during the quarter.
  • Wells Fargo sold 1 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF share in Q3 2024, an estimated $30.
  • Wells Fargo first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q1 2020 and held it in 11 quarters.
  • Wells Fargo's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $1K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q3 2024.

Based on Wells Fargo's 13F filing for Q3 2024, filed 13 Nov 2024.